Biomea Fusion, Inc. Long-term Investments
Biomea Fusion, Inc. (BMEA) had Long-term Investments of $10.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:LongTermInvestments · last filed 2023-03-28
- 2022-09-30: Long-term Investments $10.00K.
- 2022-06-30: Long-term Investments $186.00K.
- 2022-03-31: Long-term Investments $415.00K.
- 2021-12-31: Long-term Investments $1.88M.
| Period end | Long-term Investments |
|---|---|
| 2022-09-30 | $10.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $186.00K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $415.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.88M 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.24M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $4.26M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $11.84M 10-Q · filed 2021-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |